Klotho Neurosciences, Inc. is set to attend the Inaugural Klotho Conference & Scientific Seminar at the UC-Irvine Beal Applied Innovation Center in Irvine, California, on September 15-16, 2025. The biotechnology company, focused on advancing Klotho-based therapeutics for neurodegenerative diseases, will have its two key scientific advisors, Dr. Miguel Chillon and Dr. Assumpcio Bosch, present their research achievements on Klotho gene therapy in the treatment of ALS, Alzheimer's, and longevity.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: EN67229) on September 08, 2025, and is solely responsible for the information contained therein.